Bristol Myers Squibb and Pfizer are offering an insurance-free pathway to access one of their widely used blood thinners. The pharmaceutical giants launched a new direct-to-patient option for ...
Bayer’s plans to turn asundexian into a 5 billion euro ($5.5 billion) a year medicine have taken a hit. The factor XIa inhibitor had “inferior efficacy” to Bristol Myers Squibb and Pfizer’s Eliquis in ...
Opinion
17don MSNOpinion
Bristol-Myers blood thinner Eliquis offered free to Medicaid as part of U.S. pricing deal
Bristol Myers (BMY) stock is in focus as the firm to offer its Pfizer (PFE)-partnered Eliquis, free to Medicaid as part of a U.S. pricing deal. Read more here.
Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price Beginning September 8, eligible U.S. patients with an Eliquis prescription may ...
WhiteSands Alcohol & Drug Rehab Lakeland has published a new in-depth educational resource on its website examining the medical and behavioral risks associated with mixing Eliquis, a commonly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback